Spots Global Cancer Trial Database for overall response rate of ffp+rituximab combined therapy
Every month we try and update this database with for overall response rate of ffp+rituximab combined therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Combined Treatment With Fresh Frozen Plasma and Rituximab (Mabthera) in Patients With Advanced Refractory Chronic Lymphocytic Leukemia | NCT00892827 | Advanced Refrac... | Rituximab (Mabt... | 18 Years - | Wolfson Medical Center |